To investigate the potential predictive role of cytokines and tumor markers in immunotherapy efficacy, we conducted a correlation analysis between blood IL-6/IL-8 concentrations and tumor markers in AGC patients receiving immunochemotherapy. Here, CXCL8 is linked to neoplasm.